Both Tirzepatide and Mounjaro represent new approaches to addressing type 2 diabetes, and increasingly, obesity. Tirzepatide is a dual agonist that targets two receptors involved in metabolism: GLP-1 and another https://things-to-know-about-tir380125.blog2learn.com/91222846/understanding-tirzepatide-and-mounjaro-the-thorough-overview